Lexicon Pharmaceuticals Inc (LXRX)
1.16
-0.04
(-3.73%)
USD |
NASDAQ |
Nov 05, 14:40
Lexicon Pharmaceuticals Gross Profit Margin (Quarterly): 89.92% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 89.92% |
| March 31, 2024 | 97.26% |
| December 31, 2023 | 90.03% |
| September 30, 2023 | 95.68% |
| June 30, 2023 | 97.48% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 |
| Date | Value |
|---|---|
| September 30, 2020 | 90.46% |
| June 30, 2020 | 92.06% |
| March 31, 2020 | 92.90% |
| December 31, 2019 | 91.13% |
| September 30, 2019 | 99.80% |
| June 30, 2019 | 86.29% |
| March 31, 2019 | 94.00% |
| December 31, 2018 | 96.67% |
| September 30, 2018 | 92.09% |
| June 30, 2018 | 93.93% |
| March 31, 2018 | 97.90% |
| December 31, 2017 | 98.44% |
| September 30, 2017 | 97.78% |
| June 30, 2017 | 95.54% |
| March 31, 2017 | 98.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
89.92%
Minimum
Jun 2024
97.48%
Maximum
Jun 2023
92.99%
Average
92.06%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
| Viatris Inc | 38.07% |
| AIM ImmunoTech Inc | 84.00% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 29.82% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -106.6% |
| Return on Assets | -62.64% |
| Return on Invested Capital | -69.95% |
| Profit Margin (Quarterly) | -3.24K% |
| Operating Margin (Quarterly) | -3.36K% |
| Return on Net Operating Assets | -375.7% |